효과적인 리더십과 거버넌스가 보건의료 시스템 전반에서 인공지능의 책임 있는 도입을 어떻게 형성하고 있는지 살펴봅니다. 본 세션에서는 임상 진료, 운영 및 연구 분야의 실제 AI 적용 사례와 함께 안전성, 투명성 및 신뢰를 보장하는 데 필요한 프레임워크를 보여주는 주요 기관들의 통찰력을 공유합니다. 시범 운영을 넘어선 솔루션의 확장부터 디지털 생태계 내 AI 내재화에 이르기까지, 발표자들은 강력한 거버넌스, 인력의 준비성 및 협력적 리더십이 환자 중심의 치료를 유지하면서 어떻게 AI의 잠재력을 최대한 끌어낼 수 있는지 보여줄 것입니다.
의료 분야 AI 리더십 – 거버넌스, 신뢰, 시스템 전반의 통합
좌장
Ms Cathy Easter
President & CEO, Houston Methodist Global, USA
Ms. Easter is responsible for global operations, corporate strategy, business development and community engagement. Key responsibilities include establishing global strategies for Houston Methodist, as well as leading international consulting projects. Houston Methodist has one of the largest international patient programs in the United States where she provides executive oversight while leading global brand and business development.
She has been instrumental in expanding Houston Methodist’s global footprint to include eleven offices throughout Latin America and the Middle East. In addition to her global responsibilities Ms. Easter leads strategic initiatives related to market share growth within the United States through regional business development, strategic partnerships, and direct to employer offerings.
Additionally, she leads Houston Methodist Community Benefits department and grantmaking program focused on partnerships with local Federally Qualified Health Centers, free clinics, specialty services and mental health providers to ensure access to care as well as addressing social determinants of health. She is also the preceptor for the Administrative Fellows Program which is focused on developing healthcare’s future leaders.
She has been recognized for her global and community leadership, she serves on a number of Boards of Directors and is a frequent speaker on global business and health care related topics.
연사
Dr Luis Lobón
VP, Mass General Brigham International, USA
Luis Lobón, MD, MHPM, FACEP, is Vice President of Mass General Brigham International, former Vice Chair of Mass General Brigham Enterprise Emergency Medicine, and Assistant Professor of Emergency Medicine at Harvard Medical School.
A practicing physician within the Mass General Brigham Emergency Medicine Enterprise, Dr Lobón is a recognized leader in healthcare innovation with extensive international experience. He has led collaborations with ministries of health, healthcare organizations, and industry partners across the Middle East, Asia, and Latin America, advancing initiatives that strengthen health systems, expand access, improve quality, and develop future healthcare leaders. His work emphasizes global partnerships, local talent development, leadership capacity building, and innovation in care delivery and population health.
Dr Lobón is also a leader in executive healthcare education. He previously served as Program Director for the International Emergency Department Leadership Institute and directed leadership and management fellowship programs at Mass General Brigham and the University of British Columbia. He is past President of the Massachusetts College of Emergency Physicians and serves on multiple boards.
He earned his medical degree from the University of Cantabria in Spain, completed residency training at Mount Sinai and Beth Israel Medical Centers, and holds a master’s degree from New York University.
Dr Philipp Rohde
Corporate Marketing Strategy Lead, Healthcare AI, Siemens Healthineers, Germany
Dr. Philipp Rohde is the Corporate Marketing Strategy Lead for Healthcare AI at Siemens Healthineers. Since 2024, he has been responsible for shaping strategic initiatives that accelerate the adoption of a global portfolio of artificial intelligence solutions in healthcare and drive innovation, digital transformation, and sustainable growth across the healthcare sector.
Previously, he held a range of leadership positions at Siemens Healthineers in marketing, portfolio management, and business strategy, including Head of Marketing for Photon-Counting CT, Head of Portfolio Management for Cardiovascular Care, and Head of Marketing for Cardiology Solutions. His work has focused on bringing innovative imaging and cardiovascular solutions to market, shaping portfolio strategy, and translating technological advancements into clinical and customer value.
Dr Emmanuel Rupert
Managing Director and Group CEO, Narayana Hrudayalaya Ltd., India
Dr Emmanuel Rupert is the Managing Director and Group Chief Executive Officer of Narayana Health since 2019. A graduate of Banaras Hindu University, he joined Narayana Health in 2000 as Chief Consultant in Anaesthesia and Director of Academic Services. Over the years, he has served in several roles including clinician, medical administrator, and Group Medical Director before assuming his current leadership position.
Dr Rupert is widely recognized for transforming clinical expertise into strategic healthcare leadership. During the COVID-19 pandemic, his leadership strengthened clinical capacity, improved cost management, and streamlined operations, enabling the organization to recover quickly and sustain growth.
He has overseen multiple greenfield and brownfield expansions while guiding Narayana Health into a new era of healthcare innovation. A strong advocate of technology-driven healthcare, he is leading initiatives to integrate data analytics, artificial intelligence, and Iot to build a digitally enabled healthcare ecosystem.
Under his leadership, Narayana Health achieved enterprise-level accreditation from Joint Commission International, reinforcing its commitment to quality, patient safety, and clinical excellence across its healthcare network.